A New Design and Epitopes Analysis for Recombinant Vaccine against Salmonella typhi by In silico Analysis

Tahereh Bidmeshki Barzoki, A. Ahadi, H. Ayat
{"title":"A New Design and Epitopes Analysis for Recombinant Vaccine against Salmonella typhi by In silico Analysis","authors":"Tahereh Bidmeshki Barzoki, A. Ahadi, H. Ayat","doi":"10.24294/TI.V2.I4.891","DOIUrl":null,"url":null,"abstract":"Nowadays, foodborne diseases are one of the main problems of the world that infect humans due to consumption of contaminated water or food. Typhoid fever is one of the major causes of illness and death in the world caused by Salmonella typhi. Vaccination is one of the most effective approaches in order to reduction of the disease risk. The main goal of this study is designing and characterization of antigenic determinants of a fusion protein originated from S.typhi usable as an effective vaccine. In this study, the outer membrane proteins of salmonella have been considered as candidates conferring protection against typhoid. Considering the evidence, OmpA, OmpF and OmpC proteins of salmonella applied in a multivalent vaccine design. Conserved motives of these proteins were selected using the CLC software and then their extracellular regions of these peptides were identified with PRED-TMBB server. Appropriate motives were combined for design of final fusion protein. Finally epitops of designed protein with high antigenic properties were identified using BCPREDS, Ellipro, ABCpred, EpiJen, NetCTL-1.2, CTLpred, TAPpred, ProPred and VaxiJen servers. Predicted designed protein in this study reached a very high scores for antigenic indexes. Encoding Genetic construction of this fusion protein could be applied for production of the recombinant OmpA.OmpF.OmpC derived fusion protein with effective antigenic properties as a new vaccine against S.typhi. Laboratory experiments and animal challenging analyses is ongoing. ","PeriodicalId":401129,"journal":{"name":"Trends in Immunotherapy","volume":"53 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24294/TI.V2.I4.891","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Nowadays, foodborne diseases are one of the main problems of the world that infect humans due to consumption of contaminated water or food. Typhoid fever is one of the major causes of illness and death in the world caused by Salmonella typhi. Vaccination is one of the most effective approaches in order to reduction of the disease risk. The main goal of this study is designing and characterization of antigenic determinants of a fusion protein originated from S.typhi usable as an effective vaccine. In this study, the outer membrane proteins of salmonella have been considered as candidates conferring protection against typhoid. Considering the evidence, OmpA, OmpF and OmpC proteins of salmonella applied in a multivalent vaccine design. Conserved motives of these proteins were selected using the CLC software and then their extracellular regions of these peptides were identified with PRED-TMBB server. Appropriate motives were combined for design of final fusion protein. Finally epitops of designed protein with high antigenic properties were identified using BCPREDS, Ellipro, ABCpred, EpiJen, NetCTL-1.2, CTLpred, TAPpred, ProPred and VaxiJen servers. Predicted designed protein in this study reached a very high scores for antigenic indexes. Encoding Genetic construction of this fusion protein could be applied for production of the recombinant OmpA.OmpF.OmpC derived fusion protein with effective antigenic properties as a new vaccine against S.typhi. Laboratory experiments and animal challenging analyses is ongoing. 
一种新的伤寒沙门菌重组疫苗设计及表位分析
如今,食源性疾病是世界上因食用受污染的水或食物而感染人类的主要问题之一。伤寒是世界上由伤寒沙门氏菌引起的疾病和死亡的主要原因之一。疫苗接种是减少疾病风险的最有效方法之一。本研究的主要目的是设计和表征一种源自伤寒沙门氏菌的融合蛋白的抗原决定因子,该融合蛋白可用作有效的疫苗。在这项研究中,沙门氏菌的外膜蛋白被认为是具有保护伤寒的候选物质。考虑到证据,沙门氏菌的OmpA、OmpF和OmpC蛋白应用于多价疫苗设计。使用CLC软件选择这些蛋白的保守动机,然后使用PRED-TMBB服务器对这些肽的细胞外区域进行鉴定。结合合适的动机设计最终的融合蛋白。最后利用BCPREDS、Ellipro、ABCpred、EpiJen、NetCTL-1.2、CTLpred、TAPpred、ProPred和vaxxijen等服务器对设计的高抗原表位进行鉴定。本研究预测设计的蛋白抗原指标得分很高。该融合蛋白的编码与遗传构建可用于生产具有有效抗原特性的重组OmpA.OmpF.OmpC衍生融合蛋白,作为新型伤寒沙门氏菌疫苗。实验室实验和动物挑战性分析正在进行中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信